| Literature DB >> 25450772 |
Mingyun Shen1, Peichen Pan1, Youyong Li2, Dan Li3, Huidong Yu4, Tingjun Hou5.
Abstract
Farnesyltransferase (FTase) and geranylgeranyltransferase type I (GGTase-I) have crucial roles in the post-translational modifications of Ras proteins and, therefore, they are promising therapeutic targets for the treatment of various Ras-induced cancers and several other kinds of diseases. In this review, we provide an overview of the structures and biological functions of FTase and GGTase-I. Then, we summarize the typical inhibitors of FTase and GGTase-I, and highlight the drug candidates in clinical trials. In addition, we survey some recent advances in computer-aided drug design (CADD) and molecular modeling studies of FTase and GGTase-I.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25450772 DOI: 10.1016/j.drudis.2014.10.002
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851